Clinical trial / 1999
Ginkgo biloba extract significantly increased end diastolic velocity in the ophthalmic artery in healthy volunteers.
A Phase I placebo-controlled crossover trial evaluated the effect of Ginkgo biloba extract (GBE) in 11 healthy volunteers treated orally with either 40 mg GBE or placebo three times daily for 2 days, separated by a 2-week washout. GBE significantly increased end diastolic velocity (EDV) in the ophthalmic artery from 6.5 +/- 0.5 to 7.7 +/- 0.5 cm/sec (23% change, p=0.023), with no change seen with placebo (7.2 +/- 0.6 vs 7.1 +/- 0.5 cm/sec, 3% change, p=0.892). GBE did not alter arterial blood pressure, heart rate, or intraocular pressure, and no side effects related to GBE were found.
- Study type
- Phase I placebo-controlled crossover trial
- Who was studied
- 11 healthy volunteers (8 women, 3 men; age 34 +/- 3 years)
- What was measured
- Ocular blood flow via color Doppler imaging, blood pressure, heart rate, IOP
THE PAPER
Ginkgo biloba extract increases ocular blood flow velocity.
Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. J Ocul Pharmacol Ther, 1999.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.